Summary We have examined the effectiveness of photodynamic therapy against R3230AC rat mammary adenocarcinoma and human mesothelioma as xenografts in the same host. The results demonstrate that the xenografted human tumour is significantly more responsive to photodynamic treatment than the rodent mammary tumour. Studies also showed that the mesothelioma xenograft was fluence rate-and fluencedependent while the rat tumour exposed to the same conditions demonstrated neither of these dependencies. This disparity in response was not attributable to a difference in either whole-tumour uptake or subcellular distribution of the porphyrin photosensitiser. Analysis of the effects of visible irradiation on cytochrome c oxidase activity, measured in mitochondria prepared from tumours borne on hosts injected with photosensitiser, demonstrated that photoradiation-induced enzyme inhibition was significantly greater in mesothelioma than in R3230AC mammary tumour preparations. However, in parallel studies conducted in vitro, when photosensitiser and light were delivered to previously unperturbed mitochondria, rates of enzyme inhibition were not significantly different. Both tumours were established in long-term cell culture. While the uptake of porphyrin photosensitiser was equivalent in both cell lines, the R3230AC cells displayed a significantly greater photosensitivity than the mesothelioma cells. The data presented here demonstrate that the mechanisms that govern response to photodynamic therapy are complex, but in the case of these two xenografted tumours host response to therapy is not likely to play a significant role.
Diffuse malignant mesothelioma (DMM) occurs on the serosal surfaces of the body. Induction of DMM is associated with prolonged exposure to asbestos fibres, followed by a latency period of 15-30 years before appearance of symptoms that support its diagnostic confirmation (Wagner et al., 1960; McDonald & McDonald, 1980; Muscat & Wynder, 1991) . The disease presents as a sheet of malignant cells, usually containing scattered nodules up to 1 cm in diameter at the time of diagnosis. Conventional therapies fail to arrest DMM and death by suffocation occurs within 6 months to 2 years (Law et al., 1984; Alberts et al., 1988) .
Photodynamic therapy (PDT) is demonstrating efficacy against various human malignancies, including lung, bladder, oesophagus and breast. This therapy consists of systemic or topical administration of a photosensitiser, such as Photofrin Porfimer Sodium (PPS), followed by exposure of lesions to visible light 24-72 h after injection of photosensitiser. This regimen has evolved to take advantage of the reported preferential retention of specific porphyrins in tumour tissue (Gomer & Dougherty, 1979; Woodburn et al., 1992) . The light is usually delivered via fibre optics coupled to the output of a tuned dye laser. The resulting electronic excited state of the porphyrin retained in tumours initiates a photochemical reaction, which in turn forms the toxic oxygen species, singlet oxygen ('02) (Weishaupt et al., 1976; Gibson et al., 1984; Keene et al., 1986) . Intracellular oxidative damage induced by '02 occurs in lipid-rich cellular structures, such as the plasma, mitochondrial and ribosomal membranes, where accumulation of PPS is greatest because of the hydrophobic nature of its 'active' components (Moan et al., 1982; Kessel & Cheng, 1985; Dougherty & Mang, 1987) . The '02-induced damage leads to reduced cellular metabolism, morphological alterations, cytotoxicity and tumour necrosis (Hilf et al., 1986 (Hilf et al., , 1987 Berg & Moan, 1988) .
DMM, owing to its anatomical location and morphology, is a potential candidate for PDT. Pass et al. (1990) (1990) and Keller et al. (1990) found that mesothelioma cells in culture were sensitive to PDT using PPS. Employing meta-tetrahydroxyphenylchlorin (mTHPP), Ris et al. (1993) found that a 3 day interval between sensitiser administration and exposure of mesothelioma tumours in nude mice was optimum for response to PDT with this chlorin. In our laboratory, xenografted tumours, arising from H-MESO-1 cells implanted in nude mice, responded favourably to PDT, displaying drug-, fluence rate-and fluence-dependent relationships (Feins et al., 1990) , with many animals remaining tumour free for 30 or more days.
These findings, when compared with the less striking response we had observed for a rat mammary adenocarcinoma Foster et al., 1991) , led us to enquire whether the sensitivity of this human mesothelioma tumour xenograft was due to intrinsic properties of the host or to inherent sensitivity of the tumour. To address this, we compared the response to PDT of the human mesothelioma with that of the rat tumour model in the same host, the nude mouse. We also assessed the uptake of '4C-labelled polyhaematoporphyrin (PII) in whole-tumour homogenates and subcellular fractions and the effect photosensitisation might have on a selected biochemical end point. Foster et al., 1991) . All animals received care according to the guidelines of the University Committee on Animal Resources at the University of Rochester.
Materials and methods

Chemicals
PDT treatment conditions Nude mice bearing either the H-MESO-1 mesothelioma or R3230AC tumours received 5 mg kg-' PPS intraperitoneally when tumours reached 0.5-0.6 cm diameter (0.1-0.17 cc), usually 12-18 days after implantation. Twenty-four hours after injection of PPS, animals were anaesthetised with 75mgkg-' Ketalar (Parke Davis) and 6mgkg-' Rompun (Butler). Tumours were exposed transdermally to 630 nm laser irradiation (Inova 90 argon pumped dye laser, Coherent, Palo Alto, CA, USA) delivered via a fibre optic fitted with a cylindrical lens to provide a 1-cm-diameter light field. Light was delivered continuously using various power densities and total fluences; 200 mW cm-2 for 30 min = 360 J cm-2 or at 50mWcm-2 for 30, 60, 90 or 120 min to give 90, 180, 270 or 360 J cm-2 respectively. Light was also delivered using a fractionated regimen (100 mW cm-2 for 2 h at 30 s on/30 s off), which produced the best response for the R3230AC tumour in rats (Foster et al., 1991) . Tumours were measured through the skin with calipers prior and subsequent to PDT; tumour volumes were calculated using the equation for a cylinder, V = 7r2H, where r is half of the width and H is the longer dimension.
Statistical analysis Tumour growth was compared among various treatment groups by applying the log-rank test to tumour doubling times: the number of days required for tumours to double their initial, pretreatment volume. Some animals are included whose tumours did not reach 2 x initial volume prior to cessation of measurements; some were sacrificed because of morbidity unrelated to tumour burden and some attained their expected lifespan and died without tumour recurrence or volume doubling, i.e. 'cures'. Exact, small-sample P-values for the tests were computed using the program STATXACT (Cytal Software, Cambridge, MA, USA). All other statistical analyses were performed using the Student's t-test. For all tests, a two-sided P-value of less than 0.05 was considered to be a statistically significant difference.
[ Tumours and livers were surgically excised 24 h later, tissues homogenised and mitochondria prepared using a modified procedure of Gibson and Hilf (1983) . Briefly, the homogenate was prepared by weighing 2 g of tissue and adding 5 ml of buffer containing 0.33 M sucrose, 1 mM dithiothreitol, 1 mM EGTA, 0.03% bovine serum albumin and 100 mM potassium chloride. Tissues were homogenised on ice using a Polytron (PCU2-1 10; Brinkmann Industries, Westbury, NY, USA) at a setting of 6 for two 30 s bursts.
An aliquot of 200 fsl was removed from this preparation and stored at -70°C until prepared for counting. The remaining homogenate was centrifuged at 800 g for 15 min at 4°C International Centrifuge, Needham Heights, MA, USA); 200 lI of this supernatant and the pellets were saved and frozen for subsequent counting. The remaining supernatant fraction was centrifuged at 8,000 g (J-21, Beckman Industries, Palo Alto, CA, USA), and the supernatant from this step was collected, frozen and stored. The pellet from this 8,000 g centrifugation was resuspended in 2 ml of buffer and centrifuged at 15,000g. The supernatant and the mitochondrial pellets, which were resuspended in 2 ml of buffer, were saved and stored at -70°C until prepared for scintillation counting. Total protein analysis was performed on each sample using the method of Lowry et al. (1951) . Samples were thawed at room temperature and 0.1 ml added directly to 4ml of Ecoscint A (National Diagnostics, Mannville, NJ), vortexed vigorously and allowed to stand for 24 h prior to assessment of radioactivity.
In vivo -in vitro measurement of cytochrome c oxidase Separate groups of animals bearing either the R3230AC or mesothelioma tumours received 5 mg kg-' PPS i.p. 24 h prior to surgical excision of lesions and preparation of mitochondrial suspensions as described previously (Gibson & Hilf, 1983) . Aliquots of 1 ml of mitochondria were transferred to 3 ml quartz cuvettes and subsequently exposed to filtered (570-700 nm) and focused (1 cm diameter) quartz halogen irradiation deliyered at 150 mW cm2. The suspensions were stirred continuously, and 10 Iil samples were removed at selected times and analysed for cytochrome c oxidase activity as described previously (Gibson & Hilf, 1983) . The temperature in the cuvette was monitored during the irradiation period and did not rise above ambient.
In a parallel set of experiments to determine the intrinsic sensitivity of mesothelioma or R3230AC mitochondria to PPS photosensitisation, mitochondria were prepared from tumours borne in untreated animals following the above procedure. PPS was added at 2.5 ig ml-' for 5 min in the dark with intervals of mixing. Suspensions were centrifuged at 8,000 g using a microcentrifuge (B. Hermle, Germany), the supernatant discarded, mitochondria resuspended in 1 ml of buffer, irradiated with broad-band light and cytochrome c oxidase activity measured as above. Protein measurements of mitochondrial suspensions were performed according to the method of Lowry et al. (1951) .
Uptake and phototoxicity ofporphyrin in tumour cells in culture In order to determine whether there was any difference in the uptake of phototoxicity of porphyrin in either mesothelioma or R3230AC cells in culture, xenograft tumours were surgically excised and single-cell suspensions made according to the dissociation procedure described previously (Hissin & Hilf, 1978 Tables I and II) .
Analyses of the tumour growth data for treatment of mesotheliomas by PDT (Figure la and Tables I and III) demonstrated fluence dependence when light was delivered at a fluence rate of 50 mW cm2; there was a significant increase in tumour volume doubling time when 90Jcm-2 was compared with 180Jcm-2, and a nearly significant increase (P = 0.053) from 180 J cm-2 to 270 J cm-2 total fluence, while no difference was observed when 270 was compared with 360 J cm-2. All light treatments delivered continuously at this dose rate, i.e. 50 mW cm2, except for animals that received a total fluence of 90 J cm-2, produced a delay in mesothelioma growth that was significantly greater than that seen in animals receiving a total fluence of 360 J cm-2 delivered at a rate of 200 mW cm-2. Similar relationships between extent of tumour growth delay and fluence rate or total fluence were not as evident for the R3230AC xenografts exposed to PDT (Figure lb and Tables II and  III) . Although all light treatment protocols provided significant delays in tumour growth when compared with controls, no fluence rate or total fluence dependence was detected for the R3230AC tumour when intercomparisons of irradiation protocols were analysed. Comparisons of the effects of PDT on mesothelioma vs R3230AC xenografts, however, showed significantly greater control of the mesothelioma for all the total fluences except 180 J cm-2 when light was delivered at 50 mW cm-2 or when 360 J cm-2 was applied using the fractionated protocol with a fluence Tables I and II) Figure 7 , this well-to moderately differentiated The H-MESO-1 tumour consists of trabeculae and papillary tumour fronds, which are generally found surrounding a fibrovascular core. This structure is well depicted in the section presented in Figure 8 . The radius of the viable tumour cell chords is typically around 140pLm. Beyond the viable cells, necrotic and degenerating tissue is found using either haematoxylin and eosin or Masson trichrome stain. Capillaries supplying the fronds appear quite uniform in diameter (10-15 pm), and larger vessels are rare and confined to the tumour periphery. With the Masson trichrome stain, contrast is excellent between the darkly stained red cells within the vessel lumen and the surrounding tumour cells. In some larger tumours, an irregular region of cavitating necrosis is present near the centre of the lesion. Focal small clusters of lymphoid inflammatory infiltrate are found predominantly at the tumour periphery. The neoplastic cells contain a moderate amount of eosinophilic cytoplasm, moderately pleomorphic nuclei and a spectrum of indistinct to multiple prominent nucleoli. Individual tumour cell necrosis and detritus can be found. The average mitotic rate is approximately 13 per 40 x microscopic field.
Discussion
Patients with diffuse malignant mesothelioma (DMM), a disease that invades the pleural and peritoneat cavities, have an expected survival of less than 2 years (Law et al., 1984; Alberts et al., 1988; Kraup-Hansen & Hansen, 1991) . Failure to achieve favourable response to current treatments may be due to the inability to detect and treat early disease stages. The potential offered by PDT, and the fact that DMM presents as small tumour nodules embedded in a sheet of malignant cells, suggests that DMM may respond to PDT. In a previous report (Feins et al., 1990) , we found that PDT inhibited growth of human mesothelioma xenografts, with response inversely related to fluence rate, i.e. 360 J cm-2 delivered at 50 mWcm2 was more effective than the same fluence administered at fluence rates of 100 or 200 mW cm-2. Under the conditions employed in this earlier study using 50 mW cm-2, a total fluence of 180 J cm-2 appeared to be as effective as 270 or 360 J cm-2 in controlling tumour growth. We found similar results when we extended the observation time in the present study.
Although we observed a dramatic reduction in tumour growth rate, which, in comparison with data obtained for the R3230AC mammary tumours in the rats , showed that the mesothelioma was more sensitive, a number of questions remained and formed the basis for our current studies. These questions were: (a) would the suppression of mesothelioma tumour growth be maintained over a longer period of time, since our previous report consisted of an 18 day post-PDT observation time (Feins et al., 1990); was this mesothelioma peculiarly sensitive to PDT because it was studied as a xenograft?; (c) was the better response of mesothelioma to PDT intrinsic to this tumour model?
From the data (Tables I and III , Figure la) , it is apparent that prolonged mesothelioma tumour response was achieved when irradiation at 50 mW cm2 fluence rate was delivered for total fluences of > 180 Jcm2. Under these conditions, tumour growth, i.e. tumour volume doubling, occurred at a median of 40 days or longer after PDT (see footnote to Table  II) , thus extending the previous observation period by 2-4 times. When the fractionated light treatment regimen that produced the best R3230AC tumour response in rats (Foster et al., 1991) was applied to mesothelioma xenografts, striking responses were observed, with 5/7 mice showing no tumour volume doubling for observation periods of 208-371 days after PDT (Table I) .
Although the fluence rate dependence of response to PDT for mesothelioma xenografts was similar to those for R3230AC mammary tumours in rats Foster et al., 1991) , the tumour volume doubling time of mesothelioma was extended compared with the mammary tumour in the rat. These results raise the question of whether the observed difference in response was attributable to some intrinsic feature of the tumour or the host. To address the former, we also examined R3230AC tumours grown as xenografts in mice. These R3230AC xenografts did not respond as well as mesotheliomas and, surprisingly, their response was neither fluence nor fluence rate dependent as it was when they were treated in isologous hosts . In an effort to elucidate the mechanisms responsible for the different response of the two xenografts, we examined the time course of ['4C]PII uptake into both tumours; no difference was observed (Figure 2) . However, when mitochondria from these xenografts were isolated and irradiated, cytochrome c oxidase from mesotheliomas was significantly more photosensitive (Figure 3) . One explanation for this might be that the 'active' components of PPS localised in different subcellular sites in these two xenografts. This, however, was ruled out by the measurement of ['4C]PII distribution among the subcellular fractions (Table IV) . This was further supported by studies of cultured tumour cells in vitro, in which the uptake of ['4C]PII was essentially the same for mesothelioma cells and R3230AC ( Figure 5) . Unexpectedly, the cytotoxicity of PPS-induced photosensitisation of cells in culture was not equal for both cell types at various sensitiser and light doses; in most instances, the R3230AC cells were significantly more sensitive. Thus, we find that differences in response to PDT in vivo and photosensitisation in vitro are not simply related to a difference in photosensitiser concentration or its mitochondrial localisation. Ris et al. (1993) arrived at a conclusion coincidental with ours when they found that the tissue concentration of mTHPP did not correlate with mesothelioma xenograft response to PDT. These findings, combined, indicate that the level of photosensitiser sequestered in malignant tissue may not ultimately govern tumour response to PDT when studying either one tumour and different doses of photosensitisers or comparing two tumour types with the same concentration of intratumoral photosensitisers.
Others have studied various tumours and their response to PDT but, to our knowledge, none has compared two morphologically different tumours in the same host or the same tumour in different hosts. Henderson et al. (1985) reported that 90-100% of EMT6 tumours in Balb/c mice did no.t recur after PDT, whereas only 13% of RIF tumours in C3H/HeJ mice did not recur. They attributed this disparity in response to a difference in the degree of vascular damage, although they did not rule out occurrence of direct cell damage in EMT6 tumours. Nahabedian et al. (1988) , confirming those findings, combined PDT with either cisplatin or adriamycin chemotherapy; adriamycin potentiated the PDT-induced response of EMT6 tumours but was only additive in RIF tumours. Here, we observed differences in the response to PDT of two xenografts of different origin (the R3230AC rodent mammary adenocarcinoma and a human H-MESO-1 mesothelioma) in the same host.
One explanation for the disparity in response of these two tumours to PDT might be that the host haemopoietic response differs. Canti et al. (1984) demonstrated increased marrow cellularity and splenic hyperplasia after various multiple daily injections of 8-75 mg kg-' haematoporphyrin derivative (HpD) without exposure of the host to light. Similar haemopoietic responses were observed by Henderson and Stewart (1992) and Levy et al. (1992) using Photofrin II. Those studies imply that there may be haemopoietic stimulation resulting from the porphyrin photosensitiser either in vitro or in vivo and that this stimulation may occur both in the dark and after exposure to light. In this present study, we utilised the nude mouse to xenograft both tumour types, and we would expect little difference in haemopoietic response because of a number of factors. Growth of both tumours was not significantly different from growth of xenografts in the nude mouse or from the growth of R3230AC in its isologous host, the Fischer female rats. Administration of 5 mg kg-' PPS was expected to elicit the same response, particularly since photosensitiser retention and distribution in the xenografted tumours were equivalent.
The results of the present study strongly suggest that PDT response in these systems cannot be predicted on the basis of easily identified 'cell-specific' or 'host-specific' criteria.
Rather, it appears that complex factors involving tumour cell-host interactions are important and difficult to analyse. R3230AC cells, while more responsive to PDT than H-MESO-1 cells in vitro, are clearly less responsive to equivalent PDT treatment regimens in both isologous hosts and nude mice in vivo. Hence, sensitivity to PDT in vitro is not an invariable predictor of the tumour sensitivity in vivo. Further, these two tumour cell lines, when grown as subcutaneous transplants in the same host, exhibit significantly different responses to PDT. Thus, we have been unable to identify any obvious feature of the host as being responsible for tumour response.
The complexity of this is further illustrated by the fact that the R3230AC tumour exhibits a different fluence and fluence rate dependence in the two host systems. In the Fischer rat, significant prolongation of tumour regrowth is observed when reduced fluence rate or fractionated irradiation protocols are employed, indicating that therapy-induced oxygen consumption is an important limiting factor in this system. On the other hand, no such fluence rate dependence is observed for this tumour when treated as a xenograft in the nude mouse. It is possible that the R3230AC elicits a better vascular supply when grown in the mouse and that this better perfusion is responsible for the absence of a fluence rate effect (Foster & Gao, 1992) . However, it is also possible that some other factor plays the predominant limiting role. If, for example, the intratumoral distribution of PPS is significantly more heterogeneous in the xenograft system than it is in the isologous host, it may not be possible to influence the tumour response to PDT by reduction in the rate of photochemical oxygen consumption. Differences in intratumoral photosensitiser distribution would not be measured by the '4C uptake studies and biochemical assays reported here, since these represent spatial averages over the entire tumour volume. Whatever the mechanism governing the lack of a fluence rate dependence for response of the R3230AC in the mouse, it is clear that it cannot be attributable to an intrinsic property of the murine host, since pronounced fluence rate effects are observed in the mesothelioma grown in this host system.
Examination of histological sections of the two xenografts demonstrates that their morphologies are very different. Generally, the mesothelioma appears to consist of a uniform distribution of cells and vessels. The R3230AC, on the other hand, demonstrates little uniformity in either cellular distribution or vessel location and diameter. Whether these structural variations are the basis for the significant differences in response of these tumours to PDT is, as yet, unknown.
In conclusion, we find that the sensitivity of a human mesothelioma xenograft to PDT is dependent on total fluence and inversely dependent on incident fluence rate. These mesothelioma xenografts are significantly more responsive to PDT at a lower fluence rate and high total fluences than are rodent R3230AC tumour xenografts in the same host. The basis for the observed difference in sensitivity of these two xenografts could not be attributed directly to photosensitiser uptake or its subcellular localisation or to any intrinsic sensitivity studied here.
